Sort
39,280 grants matching “leukemia”
DESIGN OF NOVEL COMPLEMENT INHIBITORS
$349,743John D Lambris · University Of Pennsylvania · P01 · FY2011 · AI
Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia
$349,730Kimberly J Payne · Loma Linda University · R01 · FY2019 · CA
Linking IKKbeta activation to anti-autophagy in viral protein Tax-mediated oncoge
$349,719Hua Cheng · University Of Maryland Baltimore · R01 · FY2013 · AI
Integration of epigenetic and non-coding RNA mechanism in leukemia
$349,713Sara E Meyer · Thomas Jefferson University · R37 · FY2023 · CA
Biology and Targeting of noncoding RNAs in AML
$349,713Ramiro Garzon · Ohio State University · R01 · FY2022 · CA
Novel Topoisomerase II alpha isoform as a drug resistance determinant
$349,713Jack C. Yalowich · Ohio State University · R01 · FY2022 · CA
Novel Topoisomerase II alpha isoform as a drug resistance determinant
$349,713Jack C. Yalowich · Ohio State University · R01 · FY2023 · CA
The Biology of Mutant STAT6 in Follicular Lymphoma
$349,713Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Mechanisms and targeting of inflammatory cytokine-driven expansion and progression in AML
$349,698Anupriya Agarwal · Oregon Health & Science University · R01 · FY2019 · CA
Mechanisms and targeting of inflammatory cytokine-driven expansion and progression in AML
$349,698Anupriya Agarwal · Oregon Health & Science University · R01 · FY2021 · CA
Mechanisms and targeting of inflammatory cytokine-driven expansion and progression in AML
$349,698Anupriya Agarwal · Oregon Health & Science University · R01 · FY2020 · CA
Chaetocin as a Potential Therapy for Multiple Myeloma
$349,697Keith C Bible · Mayo Clinic Rochester · R01 · FY2011 · CA
The Role of LMO2 in the Pathogenesis of T-cell Leukemia
$349,694Utpal P Dave · Indiana University Indianapolis · R01 · FY2019 · CA
Project 1: Role of HTLV-1 Hbz in Transformation and Disease
$349,683Patrick Lee Green · Ohio State University · P01 · FY2017 · CA
Reactivation of p53 and Apoptosis in Patient Derived AML Cells with Cytoplasmic S
$349,642Charles Wayne Walker · University Of New Hampshire · R15 · FY2014 · CA
Pathways of Immune Evasion in Acute Myeloid Leukemia
$349,640Evan Ferguson Lind · Oregon Health & Science University · R01 · FY2022 · CA
Pathways of Immune Evasion in Acute Myeloid Leukemia
$349,640Evan Ferguson Lind · Oregon Health & Science University · R01 · FY2025 · CA
Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis
$349,638John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM
$349,638Chih-Chi Andrew Hu · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Targeting SIRT1 in Mantle Cell Lymphoma
$349,638Edward Seto · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis
$349,638John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · CA
Targeting EGR1 signaling pathways in diffuse large B cell lymphoma
$349,612Lixin Rui · University Of Wisconsin-Madison · R01 · FY2025 · CA
Targeting EGR1 signaling pathways in diffuse large B cell lymphoma
$349,612Lixin Rui · University Of Wisconsin-Madison · R01 · FY2022 · CA
Biodefense Project
$349,607Martha S Linet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Lymphoma Studies
$349,579Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA